Home Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy.
|

Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy.

Print
Share
Sign up for the
DRFZ NewsFlash